JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Cellebrite DI (NASDAQ:CLBT) Stock
Cellebrite DI (NASDAQ:CLBT – Get Free Report) had its target price hoisted by equities research analysts at JPMorgan Chase & Co. from $24.00 to $28.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of […]
Cellebrite DI (NASDAQ:CLBT – Get Free Report) had its target price hoisted by equities research analysts at JPMorgan Chase & Co. from $24.00 to $28.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of […]
